Mastek's record carries real cash generation and a clean audit opinion, but the surrounding picture is crowded with unresolved tax disputes, acquisition-related write-downs, and governance churn. The most material items are a fresh ₹123.58 crore income-tax addition, a full write-off of one acquisition's goodwill, and a group structure that has been restructured repeatedly since 2020.
Key findings
- Fresh ₹123.58 crore tax addition, decade-old remand, and ₹417 crore guarantees unresolved
Major- The Income Tax Department issued a Final Assessment Order for FY2022-23 (received 30 May 2026) adding ₹123.58 crore, with penalty proceedings initiated under Section 270A. The CFO stated the tax impact is approximately ₹31 crore, and an appeal was filed on June 26. A transfer-pricing addition for AY 2011-12 was remanded by ITAT with outcome unascertainable, while corporate guarantees for subsidiary Mastek Inc. stood at ₹417.37 crore as at 31 March 2026. - Acquisition-led goodwill reversing through impairments, with WACC risk flagged
Major- Consolidated goodwill rose from ₹660.12 crore (March 2021) to ₹1,780.31 crore (March 2026). Mastek wrote off ₹113.88 crore of goodwill on Taistech in FY2024-25. Management disclosed that a reasonably possible change in WACC could push Mastek US and AMEA carrying amounts above recoverable amounts as at March 31, 2025. - Reported borrowings understate economic obligations
Major- Mastek's Chennai and Mahape buildings were mortgaged as security for subsidiary loans as at March 31, 2026. The consolidated put option liability on the Evosys non-controlling interest was ₹500.35 crore as at March 31, 2021. The company maintained an unsecured credit line of ₹56 crore while its financial statements claim the group has "always been a net cash positive". - Statutory auditors of two UK subsidiaries resigned; parent auditor continues into second term
Major- Statutory auditors of Mastek (UK) Limited and Mastek Systems Company Limited, material subsidiaries, resigned effective September 18, 2025. Walker Chandiok & Co LLP was re-appointed for a second term of five consecutive years from FY2022-23 until the conclusion of the 45th AGM in 2027. The FY2024-25 consolidated financial statements could not be signed by the CFO because the position was vacant. - Group structure in continuous flux since 2020 Evosys acquisition
Major- Subsidiary count fell from 25 in FY2023-24 to 21 in FY2025-26, with one dissolution and one voluntary liquidation. In FY2023-24, put options on non-controlling interest moved to nil with a 544.3 crore credit to reserves. Nine subsidiaries reported PAT losses in FY2023-24. - CEO/CFO turnover leaves standalone statements without CFO
Major- Public institutional shareholders voted 37.12% against the CEO's appointment and 38.52% against his remuneration in a postal ballot concluded March 15, 2025. The CEO resigned effective September 3, 2024 and the CFO effective January 29, 2025. The FY2024-25 standalone financial statements were signed without a CFO.
What to watch
- Tax appeal outcome. Appeal against the FY2022-23 assessment was filed June 26, with penalty proceedings under Section 270A pending.
- Goodwill impairment test. Management flagged WACC sensitivity for Mastek US and AMEA as at March 31, 2025; next test is at March 31, 2027.
- BizAnalytica earn-out. Up to USD 24.0 million over 3 years from August 1, 2023, concluding by FY2026-27.
- UK subsidiary auditors. Successor appointment for the two firms that resigned September 18, 2025.
- MESPL merger order. NCLT Ahmedabad Bench reserved its order on April 17, 2025.
Bottom line: This is a cash-generative business with a clean audit opinion and cumulative cash flow that covers reported profit. The risk sits in the gap between the reported balance sheet and the economic obligations around it: tax disputes, acquisition goodwill, subsidiary guarantees, and a group structure that keeps moving. Watch the tax appeal, the next impairment test, and whether the subsidiary auditor vacancies get filled.